POTASSIUM CITRATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for potassium citrate and what is the scope of freedom to operate?
Potassium citrate
is the generic ingredient in two branded drugs marketed by Ut Sw Medctr, Ani Pharms, Ascent Pharms Inc, Bionpharma, Hibrow Hlthcare, Rising, Strides Pharma, Teva Pharms Usa Inc, Torrent, Zydus Pharms, and Mission Pharma, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for potassium citrate. Sixteen suppliers are listed for this compound.
Summary for POTASSIUM CITRATE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 11 |
NDAs: | 11 |
Drug Master File Entries: | 4 |
Finished Product Suppliers / Packagers: | 16 |
Raw Ingredient (Bulk) Api Vendors: | 60 |
Clinical Trials: | 62 |
Patent Applications: | 5,709 |
Drug Prices: | Drug price trends for POTASSIUM CITRATE |
What excipients (inactive ingredients) are in POTASSIUM CITRATE? | POTASSIUM CITRATE excipients list |
DailyMed Link: | POTASSIUM CITRATE at DailyMed |
Recent Clinical Trials for POTASSIUM CITRATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Utah | Phase 2/Phase 3 |
Columbia University | Phase 2/Phase 3 |
University of Pittsburgh Medical Center | Phase 2/Phase 3 |
Pharmacology for POTASSIUM CITRATE
Drug Class | Anti-coagulant Calculi Dissolution Agent |
Mechanism of Action | Acidifying Activity Calcium Chelating Activity |
Physiological Effect | Decreased Coagulation Factor Activity |
Medical Subject Heading (MeSH) Categories for POTASSIUM CITRATE
Anatomical Therapeutic Chemical (ATC) Classes for POTASSIUM CITRATE
US Patents and Regulatory Information for POTASSIUM CITRATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rising | POTASSIUM CITRATE | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 077440-002 | Jun 9, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Strides Pharma | POTASSIUM CITRATE | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 206813-002 | Sep 11, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Torrent | POTASSIUM CITRATE | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 213986-003 | Feb 6, 2024 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bionpharma | POTASSIUM CITRATE | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 212799-002 | Jun 29, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Zydus Pharms | POTASSIUM CITRATE | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 203546-003 | Aug 6, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.